News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ImmuPharma plc (IMM.L) CEO Slams Stock Plunge After Drug Trial


11/19/2009 8:18:04 AM

Bookmark and Share

Reuters -- The head of lupus specialist ImmuPharma said mid-stage trial results for its lead drug were encouraging and should not have prompted a 19 percent drop in the share price on Thursday.

Read at Reuters
Read at Wall Street Journal
Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES